icon Loading...

Company Overview

OtiTopic, Inc., founded in 2012, is a late-stage pharmaceutical company, with a track record of success in product delivery and drug device development. Otitopic has changed the route of administration of a reference listed drug (RLD) and is on track to file a 505(b)(2) NDA for sale and marketing in the US.


Investor Relations Contact

Please contact us for our executive summary


Phone: 877-443-8710


Get in touch with us for more info about OtiTopic, Inc.